BSE Live
Oct 01, 13:52Prev. Close
795.55
Open Price
799.00
Bid Price (Qty.)
808.00 (114)
Offer Price (Qty.)
808.55 (205)
NSE Live
Oct 01, 13:52Prev. Close
795.55
Open Price
799.90
Bid Price (Qty.)
808.20 (14)
Offer Price (Qty.)
808.30 (14)
Key Financial Ratios of Natco Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.20 | |
Diluted EPS (Rs.) | 105.26 | 77.34 | 39.18 | 9.32 | 24.16 | |
Cash EPS (Rs.) | 118.36 | 87.99 | 48.17 | 17.13 | 30.65 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 424.97 | 326.99 | 267.06 | 233.62 | 225.94 | |
Book Value [InclRevalReserve]/Share (Rs.) | 424.97 | 326.99 | 267.06 | 233.62 | 225.94 | |
Revenue from Operations/Share (Rs.) | 247.46 | 223.40 | 148.33 | 106.56 | 112.44 | |
PBDIT/Share (Rs.) | 142.49 | 105.00 | 57.00 | 19.86 | 38.89 | |
PBIT/Share (Rs.) | 129.35 | 94.56 | 48.02 | 12.05 | 32.49 | |
PBT/Share (Rs.) | 128.01 | 93.49 | 47.23 | 11.08 | 31.76 | |
Net Profit/Share (Rs.) | 105.22 | 77.56 | 39.19 | 9.32 | 24.24 | |
NP After MI And SOA / Share (Rs.) | 105.33 | 77.56 | 39.19 | 9.32 | 24.16 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 57.57 | 47.00 | 38.42 | 18.63 | 34.58 | |
PBIT Margin (%) | 52.27 | 42.33 | 32.37 | 11.30 | 28.89 | |
PBT Margin (%) | 51.73 | 41.85 | 31.83 | 10.39 | 28.24 | |
Net Profit Margin (%) | 42.51 | 34.71 | 26.42 | 8.74 | 21.55 | |
NP After MI And SOA Margin (%) | 42.56 | 34.71 | 26.42 | 8.74 | 21.48 | |
Return on Networth/Equity (%) | 24.78 | 23.71 | 14.67 | 3.98 | 10.69 | |
Return on Capital Employed (%) | 30.11 | 28.52 | 17.61 | 4.99 | 13.89 | |
Return on Assets (%) | 21.84 | 20.10 | 12.64 | 3.32 | 9.20 | |
Total Debt/Equity (X) | 0.04 | 0.06 | 0.03 | 0.09 | 0.06 | |
Asset Turnover Ratio (%) | 0.57 | 0.64 | 0.50 | 0.36 | 0.35 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 5.59 | 4.14 | 4.39 | 3.52 | 4.45 | |
Quick Ratio (X) | 4.77 | 3.42 | 3.30 | 2.44 | 2.93 | |
Inventory Turnover Ratio (X) | 6.04 | 0.72 | 0.63 | 0.69 | 0.56 | |
Dividend Payout Ratio (NP) (%) | 5.70 | 12.25 | 14.03 | 48.29 | 25.81 | |
Dividend Payout Ratio (CP) (%) | 5.06 | 10.80 | 11.42 | 26.26 | 20.40 | |
Earnings Retention Ratio (%) | 94.30 | 87.75 | 85.97 | 51.71 | 74.19 | |
Cash Earnings Retention Ratio (%) | 94.94 | 89.20 | 88.58 | 73.74 | 79.60 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 106.72 | 97.89 | 71.74 | 20.48 | 53.37 | |
Interest Coverage Ratios (Post Tax) (%) | 106.72 | 97.89 | 71.74 | 20.48 | 53.37 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 12,381.23 | 16,442.15 | 9,905.31 | 14,018.63 | 15,043.09 | |
EV/Net Operating Revenue (X) | 2.80 | 4.11 | 3.66 | 7.21 | 7.33 | |
EV/EBITDA (X) | 4.85 | 8.75 | 9.52 | 38.67 | 21.19 | |
MarketCap/Net Operating Revenue (X) | 3.22 | 4.26 | 3.80 | 7.11 | 7.34 | |
Retention Ratios (%) | 94.29 | 87.74 | 85.96 | 51.70 | 74.18 | |
Price/BV (X) | 1.88 | 2.91 | 2.11 | 3.24 | 3.65 | |
Price/Net Operating Revenue | 3.22 | 4.26 | 3.80 | 7.11 | 7.34 | |
Earnings Yield | 0.13 | 0.08 | 0.07 | 0.01 | 0.03 |
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
24.07.2025
23.07.2025
Natco Pharma offers to buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore
23.07.2025
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y
05.06.2025
Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y
03.06.2025
Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y
28.02.2025
Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y